

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.33906503 |
| 2 | maturation of SSU-rRNA (GO:0030490) | 5.20936464 |
| 3 | termination of RNA polymerase III transcription (GO:0006386) | 5.19979606 |
| 4 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 5.19979606 |
| 5 | proteasome assembly (GO:0043248) | 5.04792355 |
| 6 | ATP synthesis coupled proton transport (GO:0015986) | 4.95853502 |
| 7 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.95853502 |
| 8 | DNA deamination (GO:0045006) | 4.95408026 |
| 9 | 7-methylguanosine mRNA capping (GO:0006370) | 4.91500048 |
| 10 | 7-methylguanosine RNA capping (GO:0009452) | 4.85050103 |
| 11 | RNA capping (GO:0036260) | 4.85050103 |
| 12 | ribosomal small subunit biogenesis (GO:0042274) | 4.82938924 |
| 13 | synaptic vesicle maturation (GO:0016188) | 4.71855321 |
| 14 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.68090989 |
| 15 | ribosomal small subunit assembly (GO:0000028) | 4.56606450 |
| 16 | ribosomal large subunit biogenesis (GO:0042273) | 4.52191828 |
| 17 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 4.46082786 |
| 18 | rRNA modification (GO:0000154) | 4.45300701 |
| 19 | peptidyl-arginine omega-N-methylation (GO:0035247) | 4.40787503 |
| 20 | myelin maintenance (GO:0043217) | 4.36525915 |
| 21 | viral transcription (GO:0019083) | 4.33630317 |
| 22 | synaptic vesicle exocytosis (GO:0016079) | 4.32353003 |
| 23 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 4.28587855 |
| 24 | purine nucleobase biosynthetic process (GO:0009113) | 4.27312622 |
| 25 | translational termination (GO:0006415) | 4.24945574 |
| 26 | ribonucleoprotein complex biogenesis (GO:0022613) | 4.22977946 |
| 27 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.22955281 |
| 28 | protein neddylation (GO:0045116) | 4.22714889 |
| 29 | DNA replication checkpoint (GO:0000076) | 4.21759863 |
| 30 | termination of RNA polymerase I transcription (GO:0006363) | 4.19669025 |
| 31 | spliceosomal snRNP assembly (GO:0000387) | 4.17116981 |
| 32 | glutamate secretion (GO:0014047) | 4.16986448 |
| 33 | chaperone-mediated protein transport (GO:0072321) | 4.14836548 |
| 34 | transcription from RNA polymerase I promoter (GO:0006360) | 4.14594033 |
| 35 | respiratory electron transport chain (GO:0022904) | 4.01995972 |
| 36 | nucleobase biosynthetic process (GO:0046112) | 4.00388007 |
| 37 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.98843615 |
| 38 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.96816926 |
| 39 | NADH dehydrogenase complex assembly (GO:0010257) | 3.96816926 |
| 40 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.96816926 |
| 41 | positive regulation of vesicle fusion (GO:0031340) | 3.94755191 |
| 42 | electron transport chain (GO:0022900) | 3.93177327 |
| 43 | spliceosomal complex assembly (GO:0000245) | 3.91857832 |
| 44 | ribosome biogenesis (GO:0042254) | 3.91831066 |
| 45 | GTP biosynthetic process (GO:0006183) | 3.89354657 |
| 46 | cellular component biogenesis (GO:0044085) | 3.89271228 |
| 47 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.88132091 |
| 48 | rRNA processing (GO:0006364) | 3.86978589 |
| 49 | regulation of mitochondrial translation (GO:0070129) | 3.86409947 |
| 50 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.84730089 |
| 51 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.83532184 |
| 52 | cotranslational protein targeting to membrane (GO:0006613) | 3.82845387 |
| 53 | translational elongation (GO:0006414) | 3.79465853 |
| 54 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.77611470 |
| 55 | pseudouridine synthesis (GO:0001522) | 3.77229567 |
| 56 | negative regulation of ligase activity (GO:0051352) | 3.77181049 |
| 57 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.77181049 |
| 58 | protein targeting to ER (GO:0045047) | 3.77174377 |
| 59 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.77111815 |
| 60 | protein insertion into membrane (GO:0051205) | 3.74146780 |
| 61 | mitotic metaphase plate congression (GO:0007080) | 3.74001195 |
| 62 | rRNA metabolic process (GO:0016072) | 3.73499449 |
| 63 | translational initiation (GO:0006413) | 3.72242259 |
| 64 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.72098897 |
| 65 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.71776055 |
| 66 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.71429006 |
| 67 | transcription elongation from RNA polymerase II promoter (GO:0006368) | 3.69957993 |
| 68 | establishment of protein localization to mitochondrion (GO:0072655) | 3.69529866 |
| 69 | translation (GO:0006412) | 3.69159435 |
| 70 | peptidyl-histidine modification (GO:0018202) | 3.68911754 |
| 71 | protein complex biogenesis (GO:0070271) | 3.68681898 |
| 72 | protein targeting to mitochondrion (GO:0006626) | 3.67209101 |
| 73 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.63792986 |
| 74 | ribosome assembly (GO:0042255) | 3.60915643 |
| 75 | protein localization to endoplasmic reticulum (GO:0070972) | 3.59682644 |
| 76 | transcription initiation from RNA polymerase I promoter (GO:0006361) | 3.58097343 |
| 77 | UTP biosynthetic process (GO:0006228) | 3.57303860 |
| 78 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.56359944 |
| 79 | DNA-templated transcription, elongation (GO:0006354) | 3.56313299 |
| 80 | chromatin remodeling at centromere (GO:0031055) | 3.53807084 |
| 81 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.49982307 |
| 82 | CENP-A containing nucleosome assembly (GO:0034080) | 3.49205376 |
| 83 | regulation of vesicle fusion (GO:0031338) | 3.49143998 |
| 84 | rRNA methylation (GO:0031167) | 3.48584579 |
| 85 | regulation of autophagic vacuole assembly (GO:2000785) | 3.46796526 |
| 86 | positive regulation of viral transcription (GO:0050434) | 3.45614410 |
| 87 | cellular potassium ion homeostasis (GO:0030007) | 3.45444818 |
| 88 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.44074206 |
| 89 | membrane tubulation (GO:0097320) | 3.43762146 |
| 90 | L-methionine salvage (GO:0071267) | 3.43076407 |
| 91 | L-methionine biosynthetic process (GO:0071265) | 3.43076407 |
| 92 | amino acid salvage (GO:0043102) | 3.43076407 |
| 93 | cellular protein complex disassembly (GO:0043624) | 3.41773099 |
| 94 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.41622444 |
| 95 | peptidyl-arginine N-methylation (GO:0035246) | 3.39659013 |
| 96 | peptidyl-arginine methylation (GO:0018216) | 3.39659013 |
| 97 | viral life cycle (GO:0019058) | 3.37937949 |
| 98 | protein localization to mitochondrion (GO:0070585) | 3.36913183 |
| 99 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.36439111 |
| 100 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.35687116 |
| 101 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.35470960 |
| 102 | regulation of protein targeting to membrane (GO:0090313) | 3.35049463 |
| 103 | maturation of 5.8S rRNA (GO:0000460) | 3.30989945 |
| 104 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.30439499 |
| 105 | neurotransmitter secretion (GO:0007269) | 3.27907222 |
| 106 | positive regulation of ligase activity (GO:0051351) | 3.27594763 |
| 107 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.24630918 |
| 108 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.24630918 |
| 109 | histone arginine methylation (GO:0034969) | 3.24246559 |
| 110 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.22165152 |
| 111 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.21854247 |
| 112 | base-excision repair, AP site formation (GO:0006285) | 3.21742609 |
| 113 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.18588908 |
| 114 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.18588908 |
| 115 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.18588908 |
| 116 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.18185796 |
| 117 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.18185796 |
| 118 | formation of translation preinitiation complex (GO:0001731) | 3.18139977 |
| 119 | kinetochore assembly (GO:0051382) | 3.17780026 |
| 120 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.15490156 |
| 121 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.15490156 |
| 122 | positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968) | 3.14233472 |
| 123 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.12990936 |
| 124 | regulation of cellular respiration (GO:0043457) | 3.10541313 |
| 125 | response to misfolded protein (GO:0051788) | 3.02760765 |
| 126 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.99251603 |
| 127 | iron-sulfur cluster assembly (GO:0016226) | 2.98701575 |
| 128 | metallo-sulfur cluster assembly (GO:0031163) | 2.98701575 |
| 129 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.98280816 |
| 130 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.98206164 |
| 131 | negative regulation of amino acid transport (GO:0051956) | 2.96241896 |
| 132 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.94071886 |
| 133 | positive regulation of protein targeting to membrane (GO:0090314) | 2.93174854 |
| 134 | nuclear envelope reassembly (GO:0031468) | 2.90850530 |
| 135 | mitotic nuclear envelope reassembly (GO:0007084) | 2.90850530 |
| 136 | negative regulation of glycogen biosynthetic process (GO:0045719) | 2.90213638 |
| 137 | regulation of vacuole organization (GO:0044088) | 2.89248884 |
| 138 | sodium ion export (GO:0071436) | 2.87364795 |
| 139 | positive regulation of synapse maturation (GO:0090129) | 2.82369979 |
| 140 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.80544671 |
| 141 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.80356112 |
| 142 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.77625627 |
| 143 | virion assembly (GO:0019068) | 2.77534698 |
| 144 | establishment of mitochondrion localization (GO:0051654) | 2.76372644 |
| 145 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.75590288 |
| 146 | ubiquinone biosynthetic process (GO:0006744) | 2.74818433 |
| 147 | amino acid import (GO:0043090) | 2.74198721 |
| 148 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.72726250 |
| 149 | locomotory exploration behavior (GO:0035641) | 2.72624849 |
| 150 | negative regulation of glycogen metabolic process (GO:0070874) | 2.71228501 |
| 151 | protein retention in ER lumen (GO:0006621) | 2.71079690 |
| 152 | mitochondrial calcium ion transport (GO:0006851) | 2.70563608 |
| 153 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.68780553 |
| 154 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.64813403 |
| 155 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.64309186 |
| 156 | response to gravity (GO:0009629) | 2.63462501 |
| 157 | regulation of oxidative stress-induced neuron death (GO:1903203) | 2.63246167 |
| 158 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.62752586 |
| 159 | postsynaptic membrane organization (GO:0001941) | 2.62303647 |
| 160 | regulation of neurotransmitter levels (GO:0001505) | 2.59945058 |
| 161 | cullin deneddylation (GO:0010388) | 2.59454693 |
| 162 | COPI coating of Golgi vesicle (GO:0048205) | 2.57974461 |
| 163 | Golgi transport vesicle coating (GO:0048200) | 2.57974461 |
| 164 | regulation of synaptic vesicle transport (GO:1902803) | 2.55959392 |
| 165 | histone H2B ubiquitination (GO:0033523) | 2.54533599 |
| 166 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.53591768 |
| 167 | protein maturation by protein folding (GO:0022417) | 2.53288995 |
| 168 | neuronal ion channel clustering (GO:0045161) | 2.52655015 |
| 169 | mammary gland epithelial cell differentiation (GO:0060644) | 2.52621269 |
| 170 | negative regulation of microtubule polymerization (GO:0031115) | 2.52115677 |
| 171 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.51859487 |
| 172 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.51859487 |
| 173 | protein deneddylation (GO:0000338) | 2.50370600 |
| 174 | protein localization to endosome (GO:0036010) | 2.49712560 |
| 175 | axon ensheathment in central nervous system (GO:0032291) | 2.46644337 |
| 176 | central nervous system myelination (GO:0022010) | 2.46644337 |
| 177 | regulation of synaptic plasticity (GO:0048167) | 2.46582913 |
| 178 | regulation of defense response to virus by virus (GO:0050690) | 2.46489288 |
| 179 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.46276942 |
| 180 | viral protein processing (GO:0019082) | 2.45580744 |
| 181 | negative regulation of organic acid transport (GO:0032891) | 2.45360729 |
| 182 | cerebellar Purkinje cell layer development (GO:0021680) | 2.41701356 |
| 183 | behavioral response to cocaine (GO:0048148) | 2.41695405 |
| 184 | sleep (GO:0030431) | 2.40826639 |
| 185 | fatty acid elongation (GO:0030497) | 2.39926653 |
| 186 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.38632436 |
| 187 | neurotransmitter transport (GO:0006836) | 2.37923773 |
| 188 | positive regulation of DNA-templated transcription, elongation (GO:0032786) | 2.35589704 |
| 189 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.35256964 |
| 190 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.35018483 |
| 191 | regulation of catecholamine metabolic process (GO:0042069) | 2.34726186 |
| 192 | regulation of dopamine metabolic process (GO:0042053) | 2.34726186 |
| 193 | regulation of transcription elongation from RNA polymerase II promoter (GO:0034243) | 2.33724634 |
| 194 | protein localization to synapse (GO:0035418) | 2.33471547 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 5.00162753 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.94214249 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.40668249 |
| 4 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 4.26117868 |
| 5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.24712039 |
| 6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 4.11389005 |
| 7 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.86451294 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.76788748 |
| 9 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.61344005 |
| 10 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.52411796 |
| 11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.46889670 |
| 12 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.12930346 |
| 13 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.07799445 |
| 14 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.05872949 |
| 15 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.94625140 |
| 16 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.94548709 |
| 17 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.93322726 |
| 18 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.87867194 |
| 19 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.83422301 |
| 20 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.82190029 |
| 21 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.62675427 |
| 22 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.44370895 |
| 23 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.42291418 |
| 24 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.42277793 |
| 25 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.35583521 |
| 26 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.34707335 |
| 27 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.34402456 |
| 28 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.34268492 |
| 29 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.33762556 |
| 30 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.28278390 |
| 31 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.27628086 |
| 32 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.25633642 |
| 33 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.20224782 |
| 34 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.20078704 |
| 35 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.15090843 |
| 36 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 2.14943999 |
| 37 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.11932576 |
| 38 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.04282918 |
| 39 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.03612198 |
| 40 | * TTF2_22483619_ChIP-Seq_HELA_Human | 2.03307831 |
| 41 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.01653693 |
| 42 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.95781639 |
| 43 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.92979987 |
| 44 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.91275246 |
| 45 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.85267803 |
| 46 | P68_20966046_ChIP-Seq_HELA_Human | 1.83784537 |
| 47 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.82725141 |
| 48 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.78678468 |
| 49 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.73719321 |
| 50 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.73168686 |
| 51 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.72862385 |
| 52 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.70015804 |
| 53 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.68986007 |
| 54 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.68095906 |
| 55 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.67071160 |
| 56 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.65858252 |
| 57 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.62991578 |
| 58 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.61396858 |
| 59 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.60749010 |
| 60 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.59697341 |
| 61 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.58228777 |
| 62 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.51262741 |
| 63 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.51192653 |
| 64 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.49729382 |
| 65 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.49286448 |
| 66 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.48131193 |
| 67 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.48117826 |
| 68 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.47659819 |
| 69 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.45526190 |
| 70 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.43825021 |
| 71 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.43214891 |
| 72 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.42496129 |
| 73 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.40273214 |
| 74 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.37053022 |
| 75 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.34442528 |
| 76 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.34048237 |
| 77 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.33605237 |
| 78 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.32412034 |
| 79 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.31688608 |
| 80 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.31008672 |
| 81 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.30799034 |
| 82 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.30373926 |
| 83 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.29636013 |
| 84 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.29059515 |
| 85 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.27122598 |
| 86 | SA1_27219007_Chip-Seq_Bcells_Human | 1.26769285 |
| 87 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.26259176 |
| 88 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.26028820 |
| 89 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.24782209 |
| 90 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.24515937 |
| 91 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.24473564 |
| 92 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.23949425 |
| 93 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.23635881 |
| 94 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.21862122 |
| 95 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.21373008 |
| 96 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.21325982 |
| 97 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.20881250 |
| 98 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.19877311 |
| 99 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.19730760 |
| 100 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.19132017 |
| 101 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.18972174 |
| 102 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.18823532 |
| 103 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.18666767 |
| 104 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.18342439 |
| 105 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.17918898 |
| 106 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.15573542 |
| 107 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14780436 |
| 108 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.14460279 |
| 109 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.13280522 |
| 110 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.12977445 |
| 111 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.12730394 |
| 112 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.09184187 |
| 113 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.08880437 |
| 114 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.08781807 |
| 115 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.08551408 |
| 116 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08060055 |
| 117 | MAF_26560356_Chip-Seq_TH2_Human | 1.07959635 |
| 118 | KDM2B_26808549_Chip-Seq_K562_Human | 1.07599461 |
| 119 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07356207 |
| 120 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.06456618 |
| 121 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.06348480 |
| 122 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.06105493 |
| 123 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.05376161 |
| 124 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.04895207 |
| 125 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.04872285 |
| 126 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.04517299 |
| 127 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.04483285 |
| 128 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04111880 |
| 129 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.04037063 |
| 130 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.03244313 |
| 131 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.02439394 |
| 132 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.02087701 |
| 133 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.01913547 |
| 134 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.99969251 |
| 135 | MYC_22102868_ChIP-Seq_BL_Human | 0.99822443 |
| 136 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.98875497 |
| 137 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.98665925 |
| 138 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97676624 |
| 139 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.97638659 |
| 140 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.96904626 |
| 141 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.96815666 |
| 142 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.93597440 |
| 143 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90905749 |
| 144 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.90091275 |
| 145 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.89104180 |
| 146 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.86862763 |
| 147 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.85684314 |
| 148 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.84451376 |
| 149 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.83424682 |
| 150 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.82200309 |
| 151 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.81981091 |
| 152 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.81971249 |
| 153 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.79242115 |
| 154 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.78633248 |
| 155 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.77963137 |
| 156 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.76926445 |
| 157 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.75408270 |
| 158 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.75352519 |
| 159 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.75089062 |
| 160 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.74310038 |
| 161 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.73148581 |
| 162 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.73033404 |
| 163 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.72997671 |
| 164 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71533256 |
| 165 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.69286618 |
| 166 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.69235526 |
| 167 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.66888295 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 5.09956873 |
| 2 | MP0003693_abnormal_embryo_hatching | 4.93014997 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 4.61011577 |
| 4 | MP0003941_abnormal_skin_development | 3.57790333 |
| 5 | MP0000566_synostosis | 3.43800636 |
| 6 | MP0004957_abnormal_blastocyst_morpholog | 3.40607521 |
| 7 | MP0003718_maternal_effect | 3.34459048 |
| 8 | MP0003111_abnormal_nucleus_morphology | 3.00751596 |
| 9 | MP0003329_amyloid_beta_deposits | 2.99260183 |
| 10 | MP0005423_abnormal_somatic_nervous | 2.79628524 |
| 11 | MP0003635_abnormal_synaptic_transmissio | 2.77945186 |
| 12 | MP0001188_hyperpigmentation | 2.72802445 |
| 13 | MP0008058_abnormal_DNA_repair | 2.69437099 |
| 14 | MP0001968_abnormal_touch/_nociception | 2.67893849 |
| 15 | MP0004270_analgesia | 2.60992552 |
| 16 | MP0003077_abnormal_cell_cycle | 2.60272389 |
| 17 | MP0010094_abnormal_chromosome_stability | 2.58993688 |
| 18 | MP0005623_abnormal_meninges_morphology | 2.57566865 |
| 19 | MP0002064_seizures | 2.54369150 |
| 20 | MP0003123_paternal_imprinting | 2.52509935 |
| 21 | MP0008932_abnormal_embryonic_tissue | 2.49198130 |
| 22 | MP0003786_premature_aging | 2.40761336 |
| 23 | MP0002063_abnormal_learning/memory/cond | 2.39548532 |
| 24 | MP0008057_abnormal_DNA_replication | 2.38061190 |
| 25 | MP0002736_abnormal_nociception_after | 2.35840544 |
| 26 | MP0006292_abnormal_olfactory_placode | 2.32904322 |
| 27 | MP0009745_abnormal_behavioral_response | 2.31063357 |
| 28 | MP0008877_abnormal_DNA_methylation | 2.26082112 |
| 29 | MP0002163_abnormal_gland_morphology | 2.19340103 |
| 30 | MP0003136_yellow_coat_color | 2.17989567 |
| 31 | MP0002572_abnormal_emotion/affect_behav | 2.16188316 |
| 32 | MP0001502_abnormal_circadian_rhythm | 2.14101011 |
| 33 | MP0008007_abnormal_cellular_replicative | 2.12016933 |
| 34 | MP0001529_abnormal_vocalization | 2.08597791 |
| 35 | MP0003879_abnormal_hair_cell | 2.06417918 |
| 36 | MP0006036_abnormal_mitochondrial_physio | 1.98036622 |
| 37 | MP0002132_abnormal_respiratory_system | 1.97716334 |
| 38 | MP0002272_abnormal_nervous_system | 1.95591555 |
| 39 | MP0002734_abnormal_mechanical_nocicepti | 1.94610519 |
| 40 | MP0002249_abnormal_larynx_morphology | 1.93891972 |
| 41 | MP0002733_abnormal_thermal_nociception | 1.89887496 |
| 42 | MP0004185_abnormal_adipocyte_glucose | 1.86949317 |
| 43 | MP0003315_abnormal_perineum_morphology | 1.86514048 |
| 44 | MP0002735_abnormal_chemical_nociception | 1.81882988 |
| 45 | MP0002638_abnormal_pupillary_reflex | 1.79634395 |
| 46 | MP0001905_abnormal_dopamine_level | 1.79149961 |
| 47 | MP0009046_muscle_twitch | 1.75418383 |
| 48 | MP0001970_abnormal_pain_threshold | 1.73574410 |
| 49 | MP0003690_abnormal_glial_cell | 1.68976909 |
| 50 | MP0003075_altered_response_to | 1.66735839 |
| 51 | MP0009840_abnormal_foam_cell | 1.62208219 |
| 52 | MP0005409_darkened_coat_color | 1.61460642 |
| 53 | MP0001501_abnormal_sleep_pattern | 1.60198322 |
| 54 | MP0001486_abnormal_startle_reflex | 1.60187758 |
| 55 | MP0004130_abnormal_muscle_cell | 1.54880699 |
| 56 | MP0005058_abnormal_lysosome_morphology | 1.53125088 |
| 57 | MP0008995_early_reproductive_senescence | 1.52410491 |
| 58 | MP0005451_abnormal_body_composition | 1.49939131 |
| 59 | MP0008569_lethality_at_weaning | 1.47882588 |
| 60 | MP0000604_amyloidosis | 1.46132920 |
| 61 | MP0000681_abnormal_thyroid_gland | 1.44514195 |
| 62 | MP0003186_abnormal_redox_activity | 1.43900543 |
| 63 | MP0006035_abnormal_mitochondrial_morpho | 1.43682836 |
| 64 | MP0002102_abnormal_ear_morphology | 1.42544999 |
| 65 | MP0002210_abnormal_sex_determination | 1.37939967 |
| 66 | MP0006276_abnormal_autonomic_nervous | 1.36736129 |
| 67 | MP0001661_extended_life_span | 1.35603358 |
| 68 | MP0001929_abnormal_gametogenesis | 1.35418020 |
| 69 | MP0005379_endocrine/exocrine_gland_phen | 1.33427103 |
| 70 | MP0001346_abnormal_lacrimal_gland | 1.33139375 |
| 71 | MP0002277_abnormal_respiratory_mucosa | 1.32088943 |
| 72 | MP0003880_abnormal_central_pattern | 1.30389354 |
| 73 | MP0001984_abnormal_olfaction | 1.28601568 |
| 74 | MP0000920_abnormal_myelination | 1.28382715 |
| 75 | MP0000015_abnormal_ear_pigmentation | 1.26852318 |
| 76 | MP0004858_abnormal_nervous_system | 1.26728453 |
| 77 | MP0003172_abnormal_lysosome_physiology | 1.25950927 |
| 78 | MP0005410_abnormal_fertilization | 1.25050750 |
| 79 | MP0003634_abnormal_glial_cell | 1.24312453 |
| 80 | MP0002557_abnormal_social/conspecific_i | 1.24075003 |
| 81 | MP0001730_embryonic_growth_arrest | 1.22235949 |
| 82 | MP0000955_abnormal_spinal_cord | 1.20995144 |
| 83 | MP0006072_abnormal_retinal_apoptosis | 1.20792278 |
| 84 | MP0002876_abnormal_thyroid_physiology | 1.20191606 |
| 85 | MP0000678_abnormal_parathyroid_gland | 1.19020122 |
| 86 | MP0003121_genomic_imprinting | 1.18251251 |
| 87 | MP0001145_abnormal_male_reproductive | 1.17399381 |
| 88 | MP0004142_abnormal_muscle_tone | 1.17203370 |
| 89 | MP0003283_abnormal_digestive_organ | 1.16048165 |
| 90 | MP0002066_abnormal_motor_capabilities/c | 1.15833928 |
| 91 | MP0000750_abnormal_muscle_regeneration | 1.15077101 |
| 92 | MP0000537_abnormal_urethra_morphology | 1.14993768 |
| 93 | MP0009697_abnormal_copulation | 1.14534196 |
| 94 | MP0000653_abnormal_sex_gland | 1.13330495 |
| 95 | MP0004811_abnormal_neuron_physiology | 1.12777946 |
| 96 | MP0002938_white_spotting | 1.12692896 |
| 97 | MP0009333_abnormal_splenocyte_physiolog | 1.10868925 |
| 98 | MP0000026_abnormal_inner_ear | 1.09441207 |
| 99 | MP0003191_abnormal_cellular_cholesterol | 1.09403100 |
| 100 | MP0003633_abnormal_nervous_system | 1.07432876 |
| 101 | MP0005174_abnormal_tail_pigmentation | 1.07167627 |
| 102 | MP0003698_abnormal_male_reproductive | 1.05834380 |
| 103 | MP0001348_abnormal_lacrimal_gland | 1.05824290 |
| 104 | MP0002882_abnormal_neuron_morphology | 1.04351782 |
| 105 | MP0008260_abnormal_autophagy | 1.03452263 |
| 106 | MP0003938_abnormal_ear_development | 1.02017586 |
| 107 | MP0005646_abnormal_pituitary_gland | 1.00931812 |
| 108 | MP0004742_abnormal_vestibular_system | 1.00361216 |
| 109 | MP0003806_abnormal_nucleotide_metabolis | 0.98978103 |
| 110 | MP0005645_abnormal_hypothalamus_physiol | 0.98848416 |
| 111 | MP0001963_abnormal_hearing_physiology | 0.98646166 |
| 112 | MP0002160_abnormal_reproductive_system | 0.97957353 |
| 113 | MP0003122_maternal_imprinting | 0.97863188 |
| 114 | MP0000372_irregular_coat_pigmentation | 0.97020629 |
| 115 | MP0003119_abnormal_digestive_system | 0.96169826 |
| 116 | MP0002909_abnormal_adrenal_gland | 0.95685052 |
| 117 | MP0008872_abnormal_physiological_respon | 0.95432439 |
| 118 | MP0004885_abnormal_endolymph | 0.94166984 |
| 119 | MP0008874_decreased_physiological_sensi | 0.93911334 |
| 120 | MP0002067_abnormal_sensory_capabilities | 0.93392638 |
| 121 | MP0009278_abnormal_bone_marrow | 0.93173717 |
| 122 | MP0005408_hypopigmentation | 0.93111511 |
| 123 | MP0002229_neurodegeneration | 0.93023501 |
| 124 | MP0005389_reproductive_system_phenotype | 0.92184334 |
| 125 | MP0004381_abnormal_hair_follicle | 0.91182901 |
| 126 | MP0001485_abnormal_pinna_reflex | 0.91135668 |
| 127 | MP0000350_abnormal_cell_proliferation | 0.90265987 |
| 128 | MP0001440_abnormal_grooming_behavior | 0.88852996 |
| 129 | MP0001672_abnormal_embryogenesis/_devel | 0.87462231 |
| 130 | MP0005380_embryogenesis_phenotype | 0.87462231 |
| 131 | MP0002152_abnormal_brain_morphology | 0.86005416 |
| 132 | MP0000049_abnormal_middle_ear | 0.84708134 |
| 133 | MP0000778_abnormal_nervous_system | 0.84669314 |
| 134 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.84553495 |
| 135 | MP0005166_decreased_susceptibility_to | 0.84056234 |
| 136 | MP0001727_abnormal_embryo_implantation | 0.83460182 |
| 137 | MP0002751_abnormal_autonomic_nervous | 0.82702193 |
| 138 | MP0004133_heterotaxia | 0.82562813 |
| 139 | MP0001697_abnormal_embryo_size | 0.82193284 |
| 140 | MP0005395_other_phenotype | 0.80892472 |
| 141 | MP0004145_abnormal_muscle_electrophysio | 0.79337876 |
| 142 | MP0003646_muscle_fatigue | 0.79058482 |
| 143 | MP0000313_abnormal_cell_death | 0.79041692 |
| 144 | MP0002080_prenatal_lethality | 0.78464383 |
| 145 | MP0002822_catalepsy | 0.78145552 |
| 146 | MP0008961_abnormal_basal_metabolism | 0.77989181 |
| 147 | MP0000358_abnormal_cell_content/ | 0.77969406 |
| 148 | MP0002653_abnormal_ependyma_morphology | 0.76876616 |
| 149 | MP0003436_decreased_susceptibility_to | 0.75768259 |
| 150 | MP0001764_abnormal_homeostasis | 0.75046275 |
| 151 | MP0001873_stomach_inflammation | 0.74993218 |
| 152 | MP0003631_nervous_system_phenotype | 0.74698850 |
| 153 | MP0001119_abnormal_female_reproductive | 0.72664692 |
| 154 | MP0002177_abnormal_outer_ear | 0.72350282 |
| 155 | MP0002184_abnormal_innervation | 0.72045890 |
| 156 | MP0002085_abnormal_embryonic_tissue | 0.71484200 |
| 157 | MP0003787_abnormal_imprinting | 0.71071403 |
| 158 | MP0003221_abnormal_cardiomyocyte_apopto | 0.70910124 |
| 159 | MP0002127_abnormal_cardiovascular_syste | 0.70214370 |
| 160 | MP0001919_abnormal_reproductive_system | 0.69943213 |
| 161 | MP0003942_abnormal_urinary_system | 0.68518111 |
| 162 | MP0005636_abnormal_mineral_homeostasis | 0.67843939 |
| 163 | MP0002161_abnormal_fertility/fecundity | 0.67370251 |
| 164 | MP0000747_muscle_weakness | 0.67293823 |
| 165 | MP0003937_abnormal_limbs/digits/tail_de | 0.67006713 |
| 166 | MP0010386_abnormal_urinary_bladder | 0.66305632 |
| 167 | MP0001756_abnormal_urination | 0.64127364 |
| 168 | MP0008789_abnormal_olfactory_epithelium | 0.64062392 |
| 169 | MP0002069_abnormal_eating/drinking_beha | 0.63865543 |
| 170 | MP0005386_behavior/neurological_phenoty | 0.63818645 |
| 171 | MP0004924_abnormal_behavior | 0.63818645 |
| 172 | MP0003279_aneurysm | 0.63805257 |
| 173 | MP0004019_abnormal_vitamin_homeostasis | 0.62622049 |
| 174 | MP0000613_abnormal_salivary_gland | 0.62127630 |
| 175 | MP0003984_embryonic_growth_retardation | 0.60833940 |
| 176 | MP0002095_abnormal_skin_pigmentation | 0.60166688 |
| 177 | MP0005666_abnormal_adipose_tissue | 0.59862323 |
| 178 | MP0005535_abnormal_body_temperature | 0.59737804 |
| 179 | MP0001986_abnormal_taste_sensitivity | 0.59661083 |
| 180 | MP0002169_no_abnormal_phenotype | 0.58567732 |
| 181 | MP0001542_abnormal_bone_strength | 0.58561884 |
| 182 | MP0002873_normal_phenotype | 0.58130318 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 5.49066149 |
| 2 | Mitochondrial inheritance (HP:0001427) | 4.95148134 |
| 3 | Myokymia (HP:0002411) | 4.91843543 |
| 4 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.80016914 |
| 5 | Acute encephalopathy (HP:0006846) | 4.45642390 |
| 6 | Progressive macrocephaly (HP:0004481) | 4.43594364 |
| 7 | Increased CSF lactate (HP:0002490) | 4.34551412 |
| 8 | Hepatocellular necrosis (HP:0001404) | 4.33848379 |
| 9 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.02758816 |
| 10 | Increased hepatocellular lipid droplets (HP:0006565) | 4.01811419 |
| 11 | Large for gestational age (HP:0001520) | 3.92649778 |
| 12 | Hepatic necrosis (HP:0002605) | 3.88172496 |
| 13 | Birth length less than 3rd percentile (HP:0003561) | 3.87559015 |
| 14 | Cerebral hypomyelination (HP:0006808) | 3.78765798 |
| 15 | Aplasia/hypoplasia of the uterus (HP:0008684) | 3.77734276 |
| 16 | Ankle clonus (HP:0011448) | 3.72462612 |
| 17 | Breast hypoplasia (HP:0003187) | 3.68767921 |
| 18 | Abnormal number of erythroid precursors (HP:0012131) | 3.68304465 |
| 19 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.66424154 |
| 20 | Reticulocytopenia (HP:0001896) | 3.62373338 |
| 21 | Renal Fanconi syndrome (HP:0001994) | 3.61567527 |
| 22 | 3-Methylglutaconic aciduria (HP:0003535) | 3.54745825 |
| 23 | Lipid accumulation in hepatocytes (HP:0006561) | 3.46948556 |
| 24 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.43089102 |
| 25 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.39781179 |
| 26 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.39781179 |
| 27 | Macrocytic anemia (HP:0001972) | 3.33795963 |
| 28 | Increased serum lactate (HP:0002151) | 3.30457718 |
| 29 | Late onset (HP:0003584) | 3.27833069 |
| 30 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.24888164 |
| 31 | Carpal bone hypoplasia (HP:0001498) | 3.21071997 |
| 32 | Supranuclear gaze palsy (HP:0000605) | 3.20952237 |
| 33 | Diplopia (HP:0000651) | 3.17641439 |
| 34 | Abnormality of binocular vision (HP:0011514) | 3.17641439 |
| 35 | Neonatal hypoglycemia (HP:0001998) | 3.14789231 |
| 36 | Cerebral edema (HP:0002181) | 3.05305906 |
| 37 | Hypoplasia of the uterus (HP:0000013) | 3.02746256 |
| 38 | Mutism (HP:0002300) | 2.99806316 |
| 39 | Exertional dyspnea (HP:0002875) | 2.97259470 |
| 40 | Respiratory failure (HP:0002878) | 2.94950118 |
| 41 | Exercise intolerance (HP:0003546) | 2.92224147 |
| 42 | Rough bone trabeculation (HP:0100670) | 2.88035893 |
| 43 | Lactic acidosis (HP:0003128) | 2.87461443 |
| 44 | Respiratory difficulties (HP:0002880) | 2.85833199 |
| 45 | Obstructive sleep apnea (HP:0002870) | 2.85591894 |
| 46 | Broad distal phalanx of finger (HP:0009836) | 2.83909768 |
| 47 | Secondary amenorrhea (HP:0000869) | 2.76736968 |
| 48 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.75024806 |
| 49 | Vertebral compression fractures (HP:0002953) | 2.74208555 |
| 50 | Focal motor seizures (HP:0011153) | 2.70872663 |
| 51 | Increased intramyocellular lipid droplets (HP:0012240) | 2.69431717 |
| 52 | Oral leukoplakia (HP:0002745) | 2.64339488 |
| 53 | CNS demyelination (HP:0007305) | 2.62488133 |
| 54 | Optic disc pallor (HP:0000543) | 2.60896109 |
| 55 | Neuronal loss in central nervous system (HP:0002529) | 2.60698477 |
| 56 | Patellar aplasia (HP:0006443) | 2.60122024 |
| 57 | Pallor (HP:0000980) | 2.59702670 |
| 58 | Microvesicular hepatic steatosis (HP:0001414) | 2.59444914 |
| 59 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.59094161 |
| 60 | Abnormality of glycolysis (HP:0004366) | 2.53317502 |
| 61 | Increased serum pyruvate (HP:0003542) | 2.53317502 |
| 62 | Horseshoe kidney (HP:0000085) | 2.53004549 |
| 63 | Visual hallucinations (HP:0002367) | 2.52751116 |
| 64 | Progressive microcephaly (HP:0000253) | 2.48999299 |
| 65 | Akinesia (HP:0002304) | 2.46794632 |
| 66 | Leukodystrophy (HP:0002415) | 2.46477563 |
| 67 | Neurofibrillary tangles (HP:0002185) | 2.45477211 |
| 68 | Abnormal eating behavior (HP:0100738) | 2.44470972 |
| 69 | Peripheral hypomyelination (HP:0007182) | 2.44175956 |
| 70 | Spastic tetraparesis (HP:0001285) | 2.44124449 |
| 71 | CNS hypomyelination (HP:0003429) | 2.43425645 |
| 72 | Tetraplegia (HP:0002445) | 2.43133527 |
| 73 | Hyperglycinemia (HP:0002154) | 2.42955324 |
| 74 | Testicular atrophy (HP:0000029) | 2.40159732 |
| 75 | Abnormality of renal resorption (HP:0011038) | 2.39777420 |
| 76 | Delusions (HP:0000746) | 2.39247241 |
| 77 | Truncal ataxia (HP:0002078) | 2.39225426 |
| 78 | Impulsivity (HP:0100710) | 2.37881045 |
| 79 | Aplastic anemia (HP:0001915) | 2.37667788 |
| 80 | Emotional lability (HP:0000712) | 2.36253655 |
| 81 | Diminished motivation (HP:0000745) | 2.33538359 |
| 82 | Growth hormone excess (HP:0000845) | 2.33043213 |
| 83 | Pancreatic fibrosis (HP:0100732) | 2.28265421 |
| 84 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.28142680 |
| 85 | Apathy (HP:0000741) | 2.27196385 |
| 86 | Pancreatic cysts (HP:0001737) | 2.26754029 |
| 87 | Abnormal trabecular bone morphology (HP:0100671) | 2.25523967 |
| 88 | Epileptic encephalopathy (HP:0200134) | 2.24234500 |
| 89 | Absent radius (HP:0003974) | 2.23743330 |
| 90 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.22941573 |
| 91 | Abnormality of the labia minora (HP:0012880) | 2.22660821 |
| 92 | Opisthotonus (HP:0002179) | 2.21490465 |
| 93 | Slow saccadic eye movements (HP:0000514) | 2.21370810 |
| 94 | Microretrognathia (HP:0000308) | 2.21048407 |
| 95 | Spastic paraparesis (HP:0002313) | 2.20910619 |
| 96 | Loss of speech (HP:0002371) | 2.19539905 |
| 97 | Unsteady gait (HP:0002317) | 2.19328919 |
| 98 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.18200776 |
| 99 | Lethargy (HP:0001254) | 2.16100331 |
| 100 | Paraparesis (HP:0002385) | 2.13436990 |
| 101 | Ragged-red muscle fibers (HP:0003200) | 2.12513355 |
| 102 | Cleft eyelid (HP:0000625) | 2.12141492 |
| 103 | Absent forearm bone (HP:0003953) | 2.11447316 |
| 104 | Aplasia involving forearm bones (HP:0009822) | 2.11447316 |
| 105 | Hypokinesia (HP:0002375) | 2.10634746 |
| 106 | Cerebral inclusion bodies (HP:0100314) | 2.10064395 |
| 107 | Popliteal pterygium (HP:0009756) | 2.09804543 |
| 108 | Abnormality of the ileum (HP:0001549) | 2.08821596 |
| 109 | Action tremor (HP:0002345) | 2.08205358 |
| 110 | Insulin resistance (HP:0000855) | 2.07857929 |
| 111 | Increased muscle lipid content (HP:0009058) | 2.07330052 |
| 112 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.04386419 |
| 113 | Meckel diverticulum (HP:0002245) | 2.02586152 |
| 114 | Spastic gait (HP:0002064) | 2.02235473 |
| 115 | Concave nail (HP:0001598) | 2.00434430 |
| 116 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.00253147 |
| 117 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.00253147 |
| 118 | Abnormality of glycolipid metabolism (HP:0010969) | 2.00253147 |
| 119 | Hyperacusis (HP:0010780) | 1.99876376 |
| 120 | Absent thumb (HP:0009777) | 1.96223541 |
| 121 | Sleep apnea (HP:0010535) | 1.95405989 |
| 122 | Stenosis of the external auditory canal (HP:0000402) | 1.94988347 |
| 123 | Acanthosis nigricans (HP:0000956) | 1.94958387 |
| 124 | Dysmetria (HP:0001310) | 1.94746006 |
| 125 | Split foot (HP:0001839) | 1.93821601 |
| 126 | Hyperphosphaturia (HP:0003109) | 1.93516656 |
| 127 | Supernumerary spleens (HP:0009799) | 1.93037047 |
| 128 | Trismus (HP:0000211) | 1.91800319 |
| 129 | Polyphagia (HP:0002591) | 1.90741247 |
| 130 | Amniotic constriction ring (HP:0009775) | 1.89033728 |
| 131 | Abnormality of placental membranes (HP:0011409) | 1.89033728 |
| 132 | Abnormality of the preputium (HP:0100587) | 1.88008086 |
| 133 | Premature graying of hair (HP:0002216) | 1.87939390 |
| 134 | Rigidity (HP:0002063) | 1.87763766 |
| 135 | Parakeratosis (HP:0001036) | 1.87483442 |
| 136 | Pancytopenia (HP:0001876) | 1.86912612 |
| 137 | Focal dystonia (HP:0004373) | 1.85382087 |
| 138 | Craniofacial dystonia (HP:0012179) | 1.85107308 |
| 139 | Premature ovarian failure (HP:0008209) | 1.84807066 |
| 140 | Progressive muscle weakness (HP:0003323) | 1.84662895 |
| 141 | Type I transferrin isoform profile (HP:0003642) | 1.84101058 |
| 142 | Abnormal spermatogenesis (HP:0008669) | 1.83698837 |
| 143 | Triphalangeal thumb (HP:0001199) | 1.81302705 |
| 144 | Abnormality of urine glucose concentration (HP:0011016) | 1.81251041 |
| 145 | Glycosuria (HP:0003076) | 1.81251041 |
| 146 | Irregular epiphyses (HP:0010582) | 1.79683258 |
| 147 | Ureteral duplication (HP:0000073) | 1.77910395 |
| 148 | Hyperglycinuria (HP:0003108) | 1.77723077 |
| 149 | Anomalous pulmonary venous return (HP:0010772) | 1.77423924 |
| 150 | Poor suck (HP:0002033) | 1.76800904 |
| 151 | Torticollis (HP:0000473) | 1.75831935 |
| 152 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.75333578 |
| 153 | Athetosis (HP:0002305) | 1.75081549 |
| 154 | Axonal loss (HP:0003447) | 1.74339024 |
| 155 | Abnormality of magnesium homeostasis (HP:0004921) | 1.73791956 |
| 156 | Annular pancreas (HP:0001734) | 1.73105762 |
| 157 | Anxiety (HP:0000739) | 1.72407857 |
| 158 | Stridor (HP:0010307) | 1.72059079 |
| 159 | Depression (HP:0000716) | 1.71898187 |
| 160 | Epileptiform EEG discharges (HP:0011182) | 1.71440896 |
| 161 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.71182922 |
| 162 | Hypoplasia of the radius (HP:0002984) | 1.70750767 |
| 163 | Megaloblastic anemia (HP:0001889) | 1.69341077 |
| 164 | Type I diabetes mellitus (HP:0100651) | 1.68498746 |
| 165 | Choreoathetosis (HP:0001266) | 1.68452800 |
| 166 | Dementia (HP:0000726) | 1.67776269 |
| 167 | Synostosis involving the elbow (HP:0003938) | 1.67364926 |
| 168 | Humeroradial synostosis (HP:0003041) | 1.67364926 |
| 169 | Hyperparathyroidism (HP:0000843) | 1.67100005 |
| 170 | Back pain (HP:0003418) | 1.66906727 |
| 171 | Limb dystonia (HP:0002451) | 1.66557124 |
| 172 | Duplicated collecting system (HP:0000081) | 1.66284969 |
| 173 | Insomnia (HP:0100785) | 1.66007378 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 7.66509503 |
| 2 | BUB1 | 4.47119151 |
| 3 | SRPK1 | 4.23512985 |
| 4 | WEE1 | 3.56970134 |
| 5 | STK16 | 3.23447223 |
| 6 | NME2 | 3.21373655 |
| 7 | EIF2AK1 | 3.12613412 |
| 8 | CAMKK1 | 2.83178458 |
| 9 | TLK1 | 2.77827970 |
| 10 | TESK1 | 2.55577494 |
| 11 | PLK4 | 2.51053127 |
| 12 | BRSK2 | 2.43332332 |
| 13 | VRK2 | 2.23884476 |
| 14 | MKNK2 | 2.19945108 |
| 15 | PAK6 | 2.08744565 |
| 16 | NME1 | 2.01376176 |
| 17 | VRK1 | 2.00957769 |
| 18 | PRKD3 | 1.98366813 |
| 19 | EIF2AK3 | 1.93459071 |
| 20 | AKT3 | 1.88424130 |
| 21 | BRAF | 1.82570755 |
| 22 | SIK2 | 1.78769401 |
| 23 | ILK | 1.78600800 |
| 24 | ZAK | 1.68903533 |
| 25 | MKNK1 | 1.68406356 |
| 26 | LRRK2 | 1.63347263 |
| 27 | PLK1 | 1.61033732 |
| 28 | CAMKK2 | 1.54046155 |
| 29 | NTRK1 | 1.53616212 |
| 30 | PLK3 | 1.47708592 |
| 31 | EPHA4 | 1.46910662 |
| 32 | TTK | 1.45704345 |
| 33 | TSSK6 | 1.44924692 |
| 34 | ERN1 | 1.44465728 |
| 35 | IRAK3 | 1.43449420 |
| 36 | PRPF4B | 1.43445967 |
| 37 | ARAF | 1.43200033 |
| 38 | PBK | 1.41427221 |
| 39 | EPHB1 | 1.41136978 |
| 40 | ACVR1B | 1.40402746 |
| 41 | CCNB1 | 1.39787951 |
| 42 | STK38L | 1.38057370 |
| 43 | BRSK1 | 1.38025111 |
| 44 | TESK2 | 1.37576852 |
| 45 | DYRK2 | 1.32359591 |
| 46 | CDC7 | 1.28883054 |
| 47 | CASK | 1.22173484 |
| 48 | TXK | 1.21860332 |
| 49 | MST4 | 1.21278926 |
| 50 | PHKG2 | 1.20521705 |
| 51 | PHKG1 | 1.20521705 |
| 52 | PNCK | 1.19652252 |
| 53 | MARK1 | 1.19522758 |
| 54 | AURKB | 1.17973085 |
| 55 | CDK8 | 1.17163407 |
| 56 | AURKA | 1.15807554 |
| 57 | MAP3K13 | 1.15055239 |
| 58 | LMTK2 | 1.14133306 |
| 59 | TAOK2 | 1.13021978 |
| 60 | MAP3K3 | 1.12466491 |
| 61 | CHEK2 | 1.10607507 |
| 62 | SMG1 | 1.08948078 |
| 63 | DYRK3 | 1.08730991 |
| 64 | PINK1 | 1.07518071 |
| 65 | NEK2 | 1.04591156 |
| 66 | PIM2 | 1.03828719 |
| 67 | SIK1 | 0.99922047 |
| 68 | BCR | 0.99720103 |
| 69 | DAPK1 | 0.99568314 |
| 70 | NTRK2 | 0.97150834 |
| 71 | CDK9 | 0.96834646 |
| 72 | EIF2AK2 | 0.95957230 |
| 73 | EPHA2 | 0.94375356 |
| 74 | MAPK15 | 0.92868331 |
| 75 | LATS2 | 0.90312931 |
| 76 | MAP4K2 | 0.89566435 |
| 77 | CDK19 | 0.89308357 |
| 78 | PRKD2 | 0.88421521 |
| 79 | BCKDK | 0.87872833 |
| 80 | ABL2 | 0.86344772 |
| 81 | CSNK1G3 | 0.85535352 |
| 82 | DAPK2 | 0.84880285 |
| 83 | PRKCI | 0.82912962 |
| 84 | CDK7 | 0.78522575 |
| 85 | LIMK1 | 0.77088092 |
| 86 | MUSK | 0.76715461 |
| 87 | CSNK2A1 | 0.76051981 |
| 88 | MARK3 | 0.74147533 |
| 89 | STK39 | 0.73314836 |
| 90 | CAMK2B | 0.72464969 |
| 91 | CDK11A | 0.72404635 |
| 92 | PIK3CG | 0.70673627 |
| 93 | PDPK1 | 0.70008880 |
| 94 | CDK14 | 0.69637806 |
| 95 | TBK1 | 0.69336315 |
| 96 | PAK1 | 0.68992438 |
| 97 | UHMK1 | 0.68486796 |
| 98 | CSNK2A2 | 0.68358626 |
| 99 | CSNK1G1 | 0.67832736 |
| 100 | CDK15 | 0.67610230 |
| 101 | DYRK1B | 0.67239555 |
| 102 | BRD4 | 0.67236440 |
| 103 | MAP2K7 | 0.67211325 |
| 104 | RPS6KA5 | 0.65687346 |
| 105 | IRAK4 | 0.65091584 |
| 106 | OBSCN | 0.64483208 |
| 107 | CDK18 | 0.63809725 |
| 108 | ATR | 0.61887173 |
| 109 | CHEK1 | 0.61762022 |
| 110 | STK38 | 0.61089018 |
| 111 | MINK1 | 0.60229667 |
| 112 | BMPR1B | 0.59644900 |
| 113 | MYLK | 0.58823288 |
| 114 | OXSR1 | 0.56960741 |
| 115 | SCYL2 | 0.56909522 |
| 116 | PAK4 | 0.55718990 |
| 117 | MAPKAPK3 | 0.55460056 |
| 118 | PDK1 | 0.54892045 |
| 119 | PRKCZ | 0.54504227 |
| 120 | ADRBK2 | 0.53594900 |
| 121 | NEK6 | 0.51535382 |
| 122 | RPS6KA4 | 0.51319947 |
| 123 | CDK3 | 0.51203904 |
| 124 | NUAK1 | 0.50893599 |
| 125 | CAMK1 | 0.50421454 |
| 126 | KDR | 0.49989349 |
| 127 | EPHA3 | 0.49678380 |
| 128 | GRK7 | 0.48259823 |
| 129 | FES | 0.47063663 |
| 130 | MAP3K12 | 0.46952915 |
| 131 | WNK3 | 0.46906670 |
| 132 | ALK | 0.46535255 |
| 133 | CDK5 | 0.45742759 |
| 134 | MAP3K11 | 0.43678126 |
| 135 | PDK3 | 0.42782046 |
| 136 | PDK4 | 0.42782046 |
| 137 | IRAK1 | 0.41033008 |
| 138 | CSNK1G2 | 0.40229910 |
| 139 | PTK2 | 0.39459296 |
| 140 | PRKCG | 0.39294473 |
| 141 | CDK2 | 0.38296256 |
| 142 | PLK2 | 0.38275348 |
| 143 | CAMK2D | 0.37424468 |
| 144 | PASK | 0.36085075 |
| 145 | MOS | 0.35369827 |
| 146 | ATM | 0.35183470 |
| 147 | NTRK3 | 0.35161117 |
| 148 | BLK | 0.35158123 |
| 149 | ROCK2 | 0.34999585 |
| 150 | PKN1 | 0.34009767 |
| 151 | STK24 | 0.33960382 |
| 152 | TYRO3 | 0.33860852 |
| 153 | MARK2 | 0.33641884 |
| 154 | MAP2K2 | 0.33439595 |
| 155 | CAMK2G | 0.32888704 |
| 156 | GRK6 | 0.32793163 |
| 157 | CSNK1A1L | 0.32564039 |
| 158 | IRAK2 | 0.31812035 |
| 159 | CSNK1E | 0.31664649 |
| 160 | WNK4 | 0.31664066 |
| 161 | MAP4K1 | 0.30976811 |
| 162 | CDK1 | 0.30752129 |
| 163 | GRK5 | 0.30222732 |
| 164 | HIPK2 | 0.29825077 |
| 165 | CSNK1A1 | 0.29703063 |
| 166 | MAP3K8 | 0.29646299 |
| 167 | PRKCD | 0.29395973 |
| 168 | TAOK1 | 0.28643872 |
| 169 | DAPK3 | 0.28211288 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RNA polymerase_Homo sapiens_hsa03020 | 4.75655074 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 4.55039320 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 4.20655512 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.74218504 |
| 5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.42879588 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.30134178 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 3.27284615 |
| 8 | DNA replication_Homo sapiens_hsa03030 | 3.08374658 |
| 9 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.79472064 |
| 10 | Huntingtons disease_Homo sapiens_hsa05016 | 2.75010022 |
| 11 | Mismatch repair_Homo sapiens_hsa03430 | 2.70315374 |
| 12 | Spliceosome_Homo sapiens_hsa03040 | 2.61273245 |
| 13 | Protein export_Homo sapiens_hsa03060 | 2.57962798 |
| 14 | Homologous recombination_Homo sapiens_hsa03440 | 2.39450766 |
| 15 | Basal transcription factors_Homo sapiens_hsa03022 | 2.36266077 |
| 16 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.35635333 |
| 17 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.31285855 |
| 18 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.30687251 |
| 19 | RNA transport_Homo sapiens_hsa03013 | 2.23154516 |
| 20 | Alzheimers disease_Homo sapiens_hsa05010 | 2.20123201 |
| 21 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.12184310 |
| 22 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.97239506 |
| 23 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.94317375 |
| 24 | Nicotine addiction_Homo sapiens_hsa05033 | 1.87833780 |
| 25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.82778934 |
| 26 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.81641731 |
| 27 | Purine metabolism_Homo sapiens_hsa00230 | 1.73365603 |
| 28 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.71769636 |
| 29 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.69713778 |
| 30 | Base excision repair_Homo sapiens_hsa03410 | 1.63631281 |
| 31 | Cell cycle_Homo sapiens_hsa04110 | 1.55150222 |
| 32 | Sulfur relay system_Homo sapiens_hsa04122 | 1.53878138 |
| 33 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.52990856 |
| 34 | RNA degradation_Homo sapiens_hsa03018 | 1.47961892 |
| 35 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.46763517 |
| 36 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.41841889 |
| 37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.41566504 |
| 38 | Other glycan degradation_Homo sapiens_hsa00511 | 1.39432596 |
| 39 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.36919654 |
| 40 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.34523872 |
| 41 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.31136878 |
| 42 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.29785967 |
| 43 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.28974329 |
| 44 | GABAergic synapse_Homo sapiens_hsa04727 | 1.26746046 |
| 45 | Morphine addiction_Homo sapiens_hsa05032 | 1.25941636 |
| 46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.20075235 |
| 47 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.16208268 |
| 48 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.15117885 |
| 49 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.14798665 |
| 50 | Insulin secretion_Homo sapiens_hsa04911 | 1.13038343 |
| 51 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.11976989 |
| 52 | Endocytosis_Homo sapiens_hsa04144 | 1.11353162 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.05234208 |
| 54 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.04242227 |
| 55 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.03413080 |
| 56 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.97030719 |
| 57 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.94353240 |
| 58 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.91609430 |
| 59 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.90189112 |
| 60 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.89461200 |
| 61 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.89410543 |
| 62 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.88462707 |
| 63 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.87856074 |
| 64 | Circadian entrainment_Homo sapiens_hsa04713 | 0.86488755 |
| 65 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.86359685 |
| 66 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.86319167 |
| 67 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.86069835 |
| 68 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.85740102 |
| 69 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.84252915 |
| 70 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.80641255 |
| 71 | Shigellosis_Homo sapiens_hsa05131 | 0.80623155 |
| 72 | Metabolic pathways_Homo sapiens_hsa01100 | 0.79980825 |
| 73 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.76295691 |
| 74 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.75751347 |
| 75 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.75714332 |
| 76 | Prion diseases_Homo sapiens_hsa05020 | 0.74523194 |
| 77 | Long-term potentiation_Homo sapiens_hsa04720 | 0.73912436 |
| 78 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.72532516 |
| 79 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.71519065 |
| 80 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.71283800 |
| 81 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.70387805 |
| 82 | Lysosome_Homo sapiens_hsa04142 | 0.67891773 |
| 83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.67165855 |
| 84 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.66278166 |
| 85 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.64412114 |
| 86 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.63722340 |
| 87 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.62289358 |
| 88 | Salmonella infection_Homo sapiens_hsa05132 | 0.60939043 |
| 89 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.59498972 |
| 90 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.59360614 |
| 91 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58469860 |
| 92 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.56582105 |
| 93 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.55293100 |
| 94 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.53675919 |
| 95 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.52772338 |
| 96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50605519 |
| 97 | Salivary secretion_Homo sapiens_hsa04970 | 0.49504076 |
| 98 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48353354 |
| 99 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.47215201 |
| 100 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.46936338 |
| 101 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.46548961 |
| 102 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.46326194 |
| 103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44816247 |
| 104 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.43652438 |
| 105 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.43173876 |
| 106 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.42292461 |
| 107 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.42170604 |
| 108 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.41677915 |
| 109 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.41612714 |
| 110 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.41330341 |
| 111 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.41293940 |
| 112 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.40951236 |
| 113 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.40217680 |
| 114 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.39611017 |
| 115 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.39332623 |
| 116 | Hepatitis C_Homo sapiens_hsa05160 | 0.38943407 |
| 117 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.38390379 |
| 118 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.38290610 |
| 119 | Glioma_Homo sapiens_hsa05214 | 0.37928997 |
| 120 | Axon guidance_Homo sapiens_hsa04360 | 0.37377771 |
| 121 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.37232669 |
| 122 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.37039937 |
| 123 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.36946510 |
| 124 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.36501557 |
| 125 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.33042898 |
| 126 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.32344995 |
| 127 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.31847053 |
| 128 | Carbon metabolism_Homo sapiens_hsa01200 | 0.31282204 |
| 129 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.29427360 |
| 130 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.27891523 |
| 131 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.23086071 |
| 132 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.21096626 |
| 133 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.19362198 |
| 134 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.18322154 |
| 135 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.16956881 |
| 136 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.16354677 |
| 137 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.16102373 |
| 138 | Phototransduction_Homo sapiens_hsa04744 | 0.15739155 |
| 139 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15719269 |
| 140 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.14895182 |
| 141 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.13200079 |
| 142 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.12800622 |
| 143 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.12468220 |
| 144 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.12451408 |
| 145 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.10791511 |
| 146 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.10263120 |
| 147 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.10257757 |
| 148 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.09468071 |
| 149 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.08133677 |
| 150 | Histidine metabolism_Homo sapiens_hsa00340 | 0.07878188 |
| 151 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.06879345 |
| 152 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.06869232 |
| 153 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.05294124 |
| 154 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.04829542 |
| 155 | Galactose metabolism_Homo sapiens_hsa00052 | 0.04608759 |
| 156 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.04068958 |
| 157 | Peroxisome_Homo sapiens_hsa04146 | 0.02512189 |
| 158 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.01691542 |
| 159 | Alcoholism_Homo sapiens_hsa05034 | 0.01114175 |
| 160 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.00769668 |
| 161 | Chemical carcinogenesis_Homo sapiens_hsa05204 | -0.0153749 |

